Foskina B Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per g Mupirocin 20 mg, betamethasone dipropionate 500 mcg

Indications/Uses

Treatment of corticosteroid-responsive dermatoses w/ secondary bacterial infection.

Click to view Foskina B detailed prescribing information

Dosage/Direction for Use

Apply oint to affected area tid.

Click to view Foskina B detailed prescribing information

Contraindications

Hypersensitivity.

Click to view Foskina B detailed prescribing information

Special Precautions

Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. Avoid contact w/ eyes. Do not bandage, cover or wrap treated skin area. Do not apply to extensive open wounds. Pregnancy & lactation.

Click to view Foskina B detailed prescribing information

Use In Pregnancy & Lactation

Click to view Foskina B detailed prescribing information

Adverse Reactions

Burning, stinging, skin atrophy, striae, dryness, acneiform eruptions, hypopigmentation.

Storage

View Foskina B storage conditions for details to ensure optimal shelf-life.

Description

View Foskina B description for details of the chemical structure and excipients (inactive components).

Action

View Foskina B mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Topical Anti-Infectives with Corticosteroids

ATC Classification

D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Foskina B oint

Packing/Price

5 g x 1's (P514.5/tube)

Foskina B

Manufacturer:

Glenmark

Distributor:

Glenmark